Clinical Trial Update: A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients [Phase 4]

View source ↗

Summary

Phase 4 study comparing Mikelan LA ophthalmic solution 2% to Timoptol XE ophthalmic solution 0.5% in patients with glaucoma/ocular hypertension to evaluate effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Mikelan LA
• Timoptol XE (timolol)

Snippet

Sponsor: Taiwan Otsuka Pharm. Co., Ltd | Conditions: Glaucoma | Phase 4 | Status: COMPLETED